vimarsana.com
  1. Home
  2. Live Updates
  3. Hangzhou Sciwind Biosciences Co - Breaking News

Page 2 - Hangzhou Sciwind Biosciences Co News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sciwind Biosciences Reports Positive Interim Results from Phase 1c/2a Clinical Trial of XW003 (Ecnoglutide) in Overweight and Obese Adult Volunteers in China

/PRNewswire/ Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat.

Sciwind biosciences co ltdHangzhou sciwind biosciences co

Sciwind Biosciences Announces Positive Topline Results from 20-week Phase 2 Clinical Trial of XW003 (Ecnoglutide), a novel long-lasting GLP-1 analogue, in Adult Patients with Type 2 Diabetes in China

/PRNewswire/ Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat.

Prnewswire sciwind biosciences co ltdHangzhou sciwind biosciences co

Sciwind Biosciences to present Data from its GLP-1 and GIP Receptor Agonist Programs at The International Liver Congress(TM) EASL 2022

/PRNewswire/ Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focusing on discovering and developing innovative therapies to treat.

United kingdomCity ofXinle wuSciwind biosciences co ltdInternational liver congressInternational liverAnnual meetingEuropean associationChief scientific officerSaturday juneHangzhou sciwind biosciences co

Sciwind Biosciences Announces Initiation of Dosing in Phase 1 Clinical Trial Evaluating XW004, an oral tablet formulation of its Proprietary GLP-1 Analogue (Ecnoglutide)

/PRNewswire/ Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat.

Thai panPrnewswire sciwind biosciences co ltdHangzhou sciwind biosciences co

Sciwind Biosciences Announces Initiation of Patient Dosing in Phase 2b Clinical Trial Evaluating XW003, its Lead GLP-1 Drug Candidate, for the Treatment of Obesity

/PRNewswire/ Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat.

New zealandSciwind biosciencesThai panPrnewswire sciwind biosciences co ltdHangzhou sciwind biosciences co

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.